Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Oncology Precision Medicine Market


6. Market Share – Oncology Precision Medicine Market

6.1 Indication
6.2 End Users
6.3 Countries


7. Indication – Oncology Precision Medicine Market

7.1 Lung Cancer
7.2 Stomach Cancer
7.3 Colorectal Cancer
7.4 Breast Cancer
7.5 Prostate Cancer
7.6 Liver Cancer
7.7 Esophagus Cancer
7.8 Cervical Cancer
7.9 Kidney Cancer
7.10 Bladder Cancer
7.11 Other Cancers


8. End Users – Oncology Precision Medicine Market

8.1 Hospitals
8.2 Diagnostic Centers
8.3 Research & Academic Institutes
8.4 Others


9. Countries – Oncology Precision Medicine Market

9.1 North America

9.1.1 United States
9.1.2 Canada

9.2 Europe

9.2.1 United Kingdom
9.2.2 France
9.2.3 Germany
9.2.4 Italy
9.2.5 Spain
9.2.6 Others in Europe

9.3 Asia Pacific

9.3.1 Japan
9.3.2 China
9.3.3 Korea
9.3.4 Others in Asia Pacific

9.4 Latin America

9.4.1 Brazil
9.4.2 Mexico
9.4.3 Argentina
9.4.4 Colombia
9.4.5 Others in Latin America

9.5 Middle East &Africa

9.5.1 Saudi Arabia
9.5.2 UAE
9.5.3 South Africa
9.5.4 Others in Middle East and Africa

9.6 Rest of the World


10. Porter’s Five Forces Analysis – Oncology Precision Medicine Market

10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Rivalry
10.4 Threat of New Entrants
10.5 Threat of Substitutes


11. SWOT Analysis – Oncology Precision Medicine Market

11.1 Strength
11.2 Weakness
11.3 Opportunity
11.4 Threat


12. Company Analysis

12.1 F. Hoffmann – La Roche Ltd

12.1.1 Overview
12.1.2 Recent Development
12.1.3 Financial Insights

12.2 Novartis AG

12.2.1 Overview
12.2.2 Recent Development
12.2.3 Financial Insights

12.3 Bristol–Myers Squibb

12.3.1 Overview
12.3.2 Recent Development
12.3.3 Financial Insights

12.4 Eli lily and Co.

12.4.1 Overview
12.4.2 Recent Development
12.4.3 Financial Insights

12.5 Astrazeneca

12.5.1 Overview
12.5.2 Recent Development
12.5.3 Financial Insights



List of Figures

Figure-01: Global – Oncology Precision Medicine Market (Billion US$), 2018 – 2022
Figure-02: Global – Forecast for Oncology Precision Medicine Market (Billion US$), 2023 – 2028
Figure-03: Indication – Lung Cancer Market (Billion US$), 2018 – 2022
Figure-04: Indication – Forecast for Lung Cancer Market (Billion US$), 2023 – 2028
Figure-05: Indication – Stomach Cancer Market (Billion US$), 2018 – 2022
Figure-06: Indication – Forecast for Stomach Cancer Market (Billion US$), 2023 – 2028
Figure-07: Indication – Colorectal Cancer Market (Billion US$), 2018 – 2022
Figure-08: Indication – Forecast for Colorectal Cancer Market (Billion US$), 2023 – 2028
Figure-09: Indication – Breast Cancer Market (Billion US$), 2018 – 2022
Figure-10: Indication – Forecast for Breast Cancer Market (Billion US$), 2023 – 2028
Figure-11: Indication – Prostate Cancer Market (Billion US$), 2018 – 2022
Figure-12: Indication – Forecast for Prostate Cancer Market (Billion US$), 2023 – 2028
Figure-13: Indication – Liver Cancer Market (Billion US$), 2018 – 2022
Figure-14: Indication – Forecast for Liver Cancer Market (Billion US$), 2023 – 2028
Figure-15: Indication – Esophagus Cancer Market (Billion US$), 2018 – 2022
Figure-16: Indication – Forecast for Esophagus Cancer Market (Billion US$), 2023 – 2028
Figure-17: Indication – Cervical Cancer Market (Billion US$), 2018 – 2022
Figure-18: Indication – Forecast for Cervical Cancer Market (Billion US$), 2023 – 2028
Figure-19: Indication – Kidney Cancer Market (Billion US$), 2018 – 2022
Figure-20: Indication – Forecast for Kidney Cancer Market (Billion US$), 2023 – 2028
Figure-21: Indication – Bladder Cancer Market (Billion US$), 2018 – 2022
Figure-22: Indication – Forecast for Bladder Cancer Market (Billion US$), 2023 – 2028
Figure-23: Indication – Other Cancers Market (Billion US$), 2018 – 2022
Figure-24: Indication – Forecast for Other Cancers Market (Billion US$), 2023 – 2028
Figure-25: End Users – Hospitals Market (Billion US$), 2018 – 2022
Figure-26: End Users – Forecast for Hospitals Market (Billion US$), 2023 – 2028
Figure-27: End Users – Diagnostic Centers Market (Billion US$), 2018 – 2022
Figure-28: End Users – Forecast for Diagnostic Centers Market (Billion US$), 2023 – 2028
Figure-29: End Users – Research & Academic Institutes Market (Billion US$), 2018 – 2022
Figure-30: End Users – Forecast for Research & Academic Institutes Market (Billion US$), 2023 – 2028
Figure-31: End Users – Others Market (Billion US$), 2018 – 2022
Figure-32: End Users – Forecast for Others Market (Billion US$), 2023 – 2028
Figure-33: United States – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-34: United States – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-35: Canada – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-36: Canada – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-37: United Kingdom – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-38: United Kingdom – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-39: France – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-40: France – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-41: Germany – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-42: Germany – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-43: Italy – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-44: Italy – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-45: Spain – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-46: Spain – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-47: Others in Europe – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-48: Others in Europe – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-49: Japan – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-50: Japan – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-51: China – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-52: China – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-53: Korea – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-54: Korea – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-55: Others in Asia Pacific – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-56: Others in Asia Pacific – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-57: Brazil – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-58: Brazil – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-59: Mexico – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-60: Mexico – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-61: Argentina – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-62: Argentina – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-63: Colombia – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-64: Colombia – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-65: Others in Latin America – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-66: Others in Latin America – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-67: Saudi Arabia – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-68: Saudi Arabia – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-69: UAE – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-70: UAE – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-71: South Africa – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-72: South Africa – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-73: Others in Middle East and Africa – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-74: Others in Middle East and Africa – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-75: Rest of the World – Oncology Precision Medicine Market (Million US$), 2018 – 2022
Figure-76: Rest of the World – Forecast for Oncology Precision Medicine Market (Million US$), 2023 – 2028
Figure-77: F. Hoffmann – La Roche Ltd – (Billion US$), 2018 – 2022
Figure-78: F. Hoffmann – La Roche Ltd – Forecast for (Billion US$), 2023 – 2028
Figure-79: Novartis AG – (Billion US$), 2018 – 2022
Figure-80: Novartis AG – Forecast for (Billion US$), 2023 – 2028
Figure-81: Bristol–Myers Squibb – (Billion US$), 2018 – 2022
Figure-82: Bristol–Myers Squibb – Forecast for (Billion US$), 2023 – 2028
Figure-83: Eli lily and Co. – (Billion US$), 2018 – 2022
Figure-84: Eli lily and Co. – Forecast for (Billion US$), 2023 – 2028
Figure-85: Astrazeneca – (Billion US$), 2018 – 2022
Figure-86: Astrazeneca – Forecast for (Billion US$), 2023 – 2028

List of Tables

Table-01: Global – Oncology Precision Medicine Market Share by Indication (Percent), 2018 – 2022
Table-02: Global – Forecast for Oncology Precision Medicine Market Share by Indication (Percent), 2023 – 2028
Table-03: Global – Oncology Precision Medicine Market Share by End User (Percent), 2018 – 2022
Table-04: Global – Forecast for Oncology Precision Medicine Market Share by End User (Percent), 2023 – 2028
Table-05: Global – Oncology Precision Medicine Market Share by Region (Percent), 2018 – 2022
Table-06: Global – Forecast for Oncology Precision Medicine Market Share by Region (Percent), 2023 – 2028